Head-to-head · Value Score
bmiMD vs FitRx
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, FitRx a 74. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameFitRx
#148 · Grade C+ · Watch List
Est. first month
From $151/mo (quarterly plan, compounded)
Save ~89% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 74 — an est. $99/mo first month, with no teaser step-up baked in. FitRx isn't out of it: Shoppers who want insured patients seeking brand-name GLP-1 access with compounded fallback.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | FitRx |
|---|---|---|
| Value Score | 89 (A) | 74 (C+) |
| Est. first month | $99/mo | From $151/mo (quarterly plan, compounded) |
| Save vs brand-name | ~93% | ~89% |
| Semaglutide | $99/mo | From $151/mo (quarterly plan, compounded) |
| Tirzepatide | $139/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
FitRx
FitRx offers brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) with insurance coordination as low as $25/month, plus compounded semaglutide from $151/month without insurance.
Why it's a deal
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- LegitScript certified
- All 50 states + DC coverage
- Compounded semaglutide from $151/mo quarterly for uninsured patients
The fine print
- Insurance coordination may not work for all plans
- Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
- Compounded option is semaglutide only — no compounded tirzepatide
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to FitRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.